Abbott’s CardioMEMS HERO Reader Receives “CE Mark”, “Conformité Européenne”, and is approved for sale in Europe, Diagnostic and Interventional Cardiology, November 18, 2026

On 16 November 2026, Abbott received European approval (the CE mark) for its CardioMEMS HERO reader, a new device for remote heart failure monitoring. It works with a small sensor implanted in the pulmonary artery, which detects pressure changes that can signal worsening heart failure, often before symptoms appear. Patients send daily readings to their care team, so treatment can be adjusted earlier.

The new HERO reader is 60% lighter than the previous one and has built-in Wi-Fi and mobile connectivity, so patients can send readings from home or while travelling. According to Abbott, data from the United States show the system reduced heart failure hospitalisations by 57%.

Read more at this link on Diagnostic and Interventional Cardiology

TRANSLATE »
Scroll to Top